Compare CE & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CE | NOVT |
|---|---|---|
| Founded | 1918 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Industrial Machinery/Components |
| Sector | Industrials | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.3B |
| IPO Year | 2004 | 1999 |
| Metric | CE | NOVT |
|---|---|---|
| Price | $48.70 | $115.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 3 |
| Target Price | $63.39 | ★ $185.00 |
| AVG Volume (30 Days) | ★ 1.4M | 476.2K |
| Earning Date | 11-02-2026 | 11-09-2026 |
| Dividend Yield | ★ 0.25% | N/A |
| EPS Growth | ★ 23.62 | N/A |
| EPS | ★ 2.21 | 0.86 |
| Revenue | ★ $9,544,000,000.00 | $521,290,000.00 |
| Revenue This Year | $4.47 | $15.96 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | ★ $22.16 | $133.07 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $35.39 | $98.27 |
| 52 Week High | $70.70 | $176.38 |
| Indicator | CE | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 49.61 | 35.29 |
| Support Level | $43.28 | N/A |
| Resistance Level | $49.63 | $148.17 |
| Average True Range (ATR) | 2.19 | 7.48 |
| MACD | -0.06 | -2.99 |
| Stochastic Oscillator | 33.90 | 6.23 |
Celanese is a global specialty chemicals manufacturer. It operates in two segments: acetyl chain, and engineered materials. Acetyl chain profitability is exposed to commodity-linked raw materials and product pricing spreads. Engineered materials converts basic chemicals into higher-margin specialty polymers and compounds engineered for specific customer applications in automotive, medical, electronics, and industrial end markets.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.